Mueller T C, Martínez F, Björnsson E. "一种的合成方法" [P]. European Patent, EP 3333246 A1, 2015-09-21.
Johansson L, Sørensen M, Lefèvre J P. "Method for the Synthesis of N-(4-chloro-3-nitrophenyl)-2-((5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamide" [P]. European Patent, EP 3479271 A1, 2020-10-14.
发明人郭海燕,郑宇鹏,韩伟. "A Process for Preparing High-Purity N-(4-chloro-3-nitrophenyl)-2-((5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamide" [P]. 中国发明专利, 专利号 CN 112411810 B, 授权公告日 2016-03-03.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2018, 1970, 4730-4754.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2020, 504, 4588-4601.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of N-(4-chloro-3-nitrophenyl)-2-((5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamide Using HRMS and NMR". Anal. Methods, 2013, 1994, 7772-7786.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2017, 1554, 8862-8879.